Beth Israel Deaconess Medical Center (Bidmc)
Boston, Massachusetts 02215-5400
12 studies enrolling now · 39 studies all time
What they study most
Acute Respiratory Failure, Adenocarcinoma - GEJ, Adenocarcinoma Gastric Stage IV With Metastases, Adult T-Cell Leukemia/Lymphoma, Advanced Adult Hepatocellular Carcinoma, Advanced Melanoma, Atopic Dermatitis, Biomarkers, Breast Cancer, Bronchoscopy, Carotid Stenosis, Chronic Lymphocytic Leukemia
Studies at this site
- A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia — Recruiting now
- A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
- RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer — Recruiting now
- Clinical Trial of Approaches to Prostate Cancer Surgery — Recruiting now
- DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer — Recruiting now
- Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
- Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma — Recruiting now
- A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 — Recruiting now
- Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
- Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) — Running, not enrolling
- RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer — Starting soon
- BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma — Completed
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Running, not enrolling
- Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma — Starting soon
- Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma — Starting soon
- A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation — Running, not enrolling
- A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence — Running, not enrolling
- PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy — Starting soon
- Molecular Assessment and Profiling of Liver Transplant Recipients — Running, not enrolling
- The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. — Stopped early
- Understanding the Long-term Impact of COVID-19 in Adults (RECOVER) — Completed
- Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial — Completed
- A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) — Completed
- DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) — Completed
- PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma — Completed
- Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy — Withdrawn before enrolling
- Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma — Completed
- Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) — Completed
- Vesair Clinical Trial — Stopped early
- Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 — Completed
- Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
- Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) — Completed
- A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer — Completed
- A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock. — Completed
- A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors — Completed
- Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness — Completed
- Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma — Stopped early
- Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV) — Completed
- Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2) — Completed